We illustrate the use of Data Envelopment Analysis (DEA) models within process improvement work for identifying and benchmarking the best healthcare systems, in terms of most efficiently producing desirable outcomes from consumed resources. This approach is useful when comparing several systems that use multiple types of inputs (e.g., operating costs, clinicians, staff) to produce multiple outputs (e.g., outcomes, satisfaction, access), such as those commonly found in balanced scorecards and dashboard datasets, and provides the analyst with relative scores and rankings for each system, targets for each measure that would move inefficient systems to the best performance frontier, and a list of other systems to benchmark and emulate in order to improve. Modified DEA models are proposed to address four common issues that frequently arise in such contexts, including rationally constraining the weights given to each measure and handling missing, estimated or proportional data (such as adverse event or mortality rates). These models can be used to compare hospitals, departments, national healthcare systems, and regional or state systems and are useful to help understand how to improve sub-optimal processes and set feasible targets. This approach is illustrated at department, hospital, state, and country levels, with overall results showing very little correlation with less quantitative benchmarking studies.
Introduction
In quality improvement and six sigma activities, benchmarking serves an important role for identifying best practices, understanding deficiencies, and setting targets (Burstin et al., 1999) . First employed by Xerox in the 1970s, benchmarking has become a common business practice for supporting continuous process improvement and management decision making (McNair and Leibfried, 1992) . In the classic 'Six Sigma' Define, Measure, Analyse, Improve, Control (DMAIC) approach, for example, benchmarking can contribute to the measurement, analysis, and improvement activities. This paper discusses and illustrates the use of Data Envelopment Analysis (DEA) for benchmarking healthcare systems within these types of process improvement or Six Sigma contexts. The intent is to illustrate how DEA can be used within these contexts through a variety of examples, rather than provide a comprehensive review of DEA theory or detailed results of each study; where appropriate references are provided to such information and to each of the cited studies.
In general, benchmarking activities compare processes across organisations (Stevenson, 1998) , including efforts to identify potential comparison partners, understand relative strengths and weaknesses, identify areas for improvement, determine gaps, and set goals (Collins-Fulea et al., 2005 ). An experience of Westinghouse's Electric Systems Division is a successful example, becoming world class in part by adapting better processes for material handling from Texas Instruments, subcontracting from Boeing, and work team organisation from Rockwell. Within healthcare, a study by Solucient found that annually 57 000 additional patients would survive, 18% fewer medical complications would occur, average hospital lengths of stay would decrease significantly, and $9.5 billion would be saved if all hospitals in the USA performed as well as the best hospitals (Chenoweth, 2003) .
Despite the clear value of identifying and transferring best practices, many benchmarking approaches are fairly subjective in the manner by which they weight performance metrics and determine top performers, often including qualitative comparisons, questionnaires and surveys, expert assessments, and case study comparisons. Often some type of score is computed for each organisation by applying largely subjective weights or ranks to various measures, as described below. Additionally, while most benchmarking tools identify an organisation's relative strengths, few provide additional information to help the underperforming organisations improve, set goals, and identify peer organisations to emulate. In contrast, DEA is a quantitative optimisation method for comparing entities (called Decision-making Units or DMUs) in order to mathematically determine their relative efficiencies, assign weights to each variable, set targets, and identify the best DMUs for further study.
Methodology

Efficiency frontier model
Originally developed within the operations research and econometrics communities, data envelopment analysis is a mathematical method, based in linear programming models, for comparing the relative efficiencies of multiple decision-making units at transforming the multiple types of inputs each consumes into the types of multiple outputs each produces (Charnes et al., 1981; Cooper et al., 2000) . Inputs might include the number of clinical staff, nurse-to-patient levels, and operating costs per patient day, whereas outputs might include clinical outcomes, access, patient satisfaction, and safety. DEA mathematically compares these measures across all DMUs in order to construct a production efficiency or 'best-practice' frontier consisting of those organisations that achieve the best weighted combination of maximal outputs from minimal inputs (Medina-Borja et al., 2007) .
Conceptually, the most efficient DMUs define an 'efficiency frontier' that envelops all the other DMUs, as illustrated graphically in Figure 1 for a simple one-input one-output case, where the horizontal and vertical axes correspond to input and output levels, respectively. In this example, the DMUs labelled A, B, and C comprise the Variable Returns-to-Scale (VRS) frontier, whereas the inefficient DMUs D, E, and F can reach this frontier by producing either the same amount of output with less input or more output with same amount of input. Mathematically, a set of fractional optimisation programmes based on total weighted output-over-input ratios (transformed into Linear Programmes (LPs) for ease of solution) is solved to determine four results for each DMU:
1 an overall efficiency score between 0 and 1 relative to the other DMUs (where a score of 1 indicates the DMU (e.g., facility) is on the frontier) 2 optimal weights for each input and output that maximise this score relative to those of all other DMUs 3 target values for each input and output that would move this DMU onto the efficiency frontier (if not currently best-in-class) 4 a subset list of the other DMUs that form a reference set for further study and benchmarking (where becoming a weighted combination of these DMUs would move a non-frontier entity to best in class). 
VRS frontier
These LPs are solved iteratively, once for each DMU, along with first and second phase dual models (Cooper et al., 2000) to produce the results described above. While several different formulations exist, in general all DEA models seek to maximise the ratio of a weighted sum of outputs over a weighted sum of inputs, as shown in Table 1 , where K is the number of DMUs, M is the number of outputs, N is the number of inputs, and e is the current DMU being measured. DEA models can assume either Constant Returns-to-Scale (CRS) or VRS in the relationship between inputs and outputs, as illustrated in Figure 1 , and can be input-or output-oriented. An input-oriented model aims to minimise the level of inputs while producing the same level of outputs, whereas an output-oriented model aims to maximise the level of outputs while consuming the same level of inputs. These two orientation formulations identify the same efficient and inefficient DMUs (in the CRS case with the output-oriented efficiency score equal to the reciprocal of that of the input-oriented model), but with different targets, weights, and reference sets. Figure 2 illustrates the general framework of a typical DEA study, here comparing six hypothetical hospitals each with three inputs (cost/charge ratio, FTE/bed ratio, and a case-mix adjusted average length of stay index) and three outputs (adjusted mortality, patient satisfaction, and access) that might be desirable to minimise and maximise, respectively (since outputs are maximised in DEA, mortality rates were converted to non-mortality rates). As shown, Hospitals 4 and 6 are top ranked and on the frontier (with scores of 1.0) and appear in the peer benchmark sets of the other four hospitals, implying that the others can improve by studying and emulating them. The next step in such an analysis would be to conduct an in-depth study of these two hospitals to develop insights as to how they are able to perform better. In order to illustrate this approach and the breadth of uses of DEA within healthcare, several recent studies are summarised below, at times using modified models as described in the following section. 
DEA Results
Hospital
Note:
Mortality is converted to non-mortality in order to be a 'larger is better' output.
Model extensions
Two modelling issues that frequently arise in many healthcare applications include proportional data (often estimated or missing) and irrational weights computed for some measures. In the first case, many key healthcare data are proportions bound between 0 and 1 (such as mortality, infection, adverse event, and appointment access rates), violating the usual DEA assumption that all data can take any positive value. Similar data also arise in other industries, such as defect, graduation, and customer retention rates. Scalar data bound on a fixed interval present a similar problem, such as patient satisfaction scores between 1 and 5 or life expectancies, as opposed to being unbounded above.
Solving conventional CRS models in such cases theoretically can produce nonsensical target values that exceed their upper possibilities (e.g., 130% survival or 420 years life expectancy). Borrowing an idea from logistic regression (Amemiya, 1985) , a simple Odds-Ratio (OR) transformation instead can be used to ensure all targets lie within their logical bounds, converting each proportion p on the (0,1) interval to a positive real number odds ratio p/(1 -p), offering the modeller an easy alternative when VRS relationships are not appropriate; notationally:
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The impact of this approach on efficiency scores, weights, reference sets, peer weights, and targets is illustrated below and explored in greater detail by Benneyan and Sunnetci (2008) . Approaches to the related modelling problems of non-proportional data bound on an (a, b) interval (such as ratings between 1 and 10), estimated probabilities, and missing data also are discussed by the above authors, Ceyhan and Benneyan (2008) , Benneyan et al. (2006) , and Aksezer and Benneyan (2003) , including multiple imputation, bootstrapping, and Monte Carlo methods. A second periodic problem that arises when using DEA to benchmark healthcare systems is the production of 'irrational' weights, such as placing greater weight on patient satisfaction than on mortality (in the extreme case with zero weight essentially ignoring important variables). Several possible modelling approaches to address this problem are summarised in Table 2 and described below, the first two taken from the DEA literature, along with their advantages and disadvantages.
The simplest approach is to rank order all weights via additional constraints that force the desired relative ordering, e.g., u 2 ≥ u 4 or v 1 ≥ v 2 ≥ v 3 , although this typically produces equal weights if the constraint would have been violated in the unbounded case. A second frequent approach is to assign upper or lower bounds to weights, such as v 1 ≥ a or u 2 ≤ b where a and b are some desired constants. Since weights mathematically are unbounded above, however, these values are somewhat meaningless. An extension of this idea that lends more meaning, however, is to specify or bound the percentages that each measure can receive from the total weight given to all measures, e.g., . These Percent-of-Total (POT) constraints can be limited further to desired ranges, i.e., a i ≤ g i ≤ b i and c j ≤ h j ≤ d j , or only specified for some of the weights. Table 2 Possible weight-restricting approaches, advantages, and disadvantages
Approach Example Advantages Disadvantages
Simple ranking
Easily applied.
Prevents the problem of allowing more weight on less important variables.
Does not prevent zero weights.
Typically produces equal weights (e.g., u 2 = u 1 ).
Prevents problems of irrational ranking and zero weights.
Lower bounds lack much meaning since weights are unbounded above.
Difficult to determine or agree on arbitrary bounds.
Frequently a feasible solution cannot be found (especially if lower bound >> zero).
Percent of Total (POT)
Prevents both above problems. Hard to determine specific percentages, which are still somewhat subjective.
Notes: First two methods in literature, third method is proposed here.
Given that these POT g i and h j values also may be somewhat subjective, the fraction of the entire possible (g i , h j ) space can be identified for which each particular DMU is efficient, referred to here as its 'hyper-efficiency score', with any DMUs on the frontier for all possible values called 'hyper-efficient'. These results can be identified or estimated by iterative search, numerical methods, or a Monte Carlo scattering approach that repeatedly solves the DEA models using random (g i , h j ) values, somewhat measuring a DMU's efficiency robustness using any set of weights. An alternate method to address arbitrary weights, called cross-efficiency, computes the average efficiency score for each DMU based only on the optimal weights of all other DMUs (Sexton et al., 1986; Doyle and Green, 1994) , in essence considering how efficient a DMU would be using (only) the weights of the other DMUs.
In the below examples, all analyses were conducted using CRS output-oriented models with all proportions and scalar data transformed to OR and all smaller-is-better outputs (such as AE and mortality rates) subtracted from 1; weight-restrictions or missing data imputation are noted when used and weighting robustness is measured via hyper-efficiency.
Applications
Hospital benchmarking
To illustrate a basic DEA study and the above modelling approaches, Table 3 summarises an analysis of 17 hospitals, where the provided inputs were the costs of administration and support, information systems, supplies, lab and imaging, nursing, and ancillary services and rehabilitation. The outputs of interest were various clinical outcome and patient safety measures (surgery quality, Cesarean related quality, failure to rescue rates, surgery adverse event rates, delivery adverse event rates, and post operation adverse event rates) that also serve as surrogates for the overall process quality. For each hospital in Table 3 , the first, second, and third rows contain their current data, targets, and weights, respectively.
As shown in the second column, seven hospitals are on the best-practice frontier (with scores of 1.0 and targets equal to their original values since they already are the top performers). The challenge for inefficient hospitals is to benchmark those on the frontier (or find other ways to reduce their inputs and increase their outputs to their computed targets) in order to become as good as those with scores of 1. For example, Hospital 1 would become top-ranked if it could change its inputs and outputs to the target levels shown in its second row (i.e., reduce its administration and support costs from $3,619 to $1,578 and its surgery adverse event rate from .0473 to .0003, along with the other targets).
Also note that, as described above, the DEA model set several weights irrationally in order to maximise some DMUs' scores. Hospital 2, for example, has been made to appear efficient by setting the weights equal to zero for inputs 1, 2, 5, and 6 and for outputs 1, 2, 3, 4, and 5, placing little to no weight on measures for which this hospital performs poorly. Additionally, Cesarean related quality has been weighted significantly lower (by more than 90%) than surgery quality.
In a similar analysis, Table 4 summarises unrestricted DEA results for the US News and World Report (USNWR) annual published study of the best US hospitals, which in 2007 placed 17 hospitals on an 'honour roll'. As above, the first and second rows for each hospital contain the targets and weights, whereas the first and second (in parentheses) values in the score column are the DEA and USNWR scores, respectively, where the USNWR results were computed using a subjective weighting scheme where structure, process, and outcome measures each received one-third of the weight (McFarlane et al., 2007) . Duke University Medical Center, for example, would become top-ranked if it could achieve the target values shown in its first row. Note again, however, that some measures receive zero or irrational weights (highlighted in italics and grey shading, respectively).
As shown in Figure 3 , furthermore, in contrast to the USNWR scores (R 2 = 0.8535, p = 0.00000005), the hospital-wide and average department DEA scores (unrestricted) have little correlation to each other (R 2 = 0.1288, p = 0.1436). The DEA results were calculated by solving a separate model for the hospitals and for each type of department, as described below, with low and variable correlations between departments suggesting process and practice differences within hospitals. The correlations in Table 5 summarise these differences for both the DEA and USNWR results. Table 3 Example of a hospital benchmarking DEA study Notes: For each hospital, C = current performance data (Row 1), T = target to be on frontier (Row 2), W = weight assigned to measure (Row 3). AE and failure-to-rescue output rates converted to non-AE and non-failure rates. USNWR results shown in parentheses.
Department benchmarking
Since multiple departments contribute to the overall performance of a hospital, separate benchmarking across each specialty also can be useful. For example, Sunnetci and Benneyan (2008) applied conventional and weight-restricted DEA models to the above 12 specialty departments examined by USNWR. For the sake of illustration, results are presented here only for the Ear, Nose, and Throat (ENT) departments. Table 6 and  Table 7 summarise the best practice ENT departments found in that study (with DEA scores equal to 1.0) and a subset of the full results for all ENT departments, respectively, with the USNWR results shown in parentheses. These results again illustrate poor agreement with the USNWR findings and the common problem of zero or irrational weights in unrestricted models (cells with italic font and grey shading in Table 7 ). The University of Washington Medical Center (UWMC), for example, places less weight on non-mortality than on reputation, whereas the University of California Hospital in San Francisco (UCSF) places no weight on non-mortality, advanced services, and patient services. Table 8 illustrates how results change when the weight restriction approaches described in Section 2.3 were applied, using the bounds shown in Column 2, with different hospitals being efficient based on the particular approach and bound values used. Table 9 summarises the efficiency score means and standard deviations for each department from 1000 replications using uniformly distributed POT weights, with the Ochsner Clinic Foundation in New Orleans being the only hyper-efficient hospital, meaning it will always be on the frontier for any possible POT bounds. In contrast, Memorial Sloan-Kettering Cancer Center and University of CA San Francisco Medical Center are on the frontier for only 28% and 2.4% of the (g i , h j ) space respectively (based on 1000 replications), and no other ENT departments ever were efficient -including those shown in shaded cells previously on the unrestricted frontier when at least one input or output was ignored, presumably due to the small number of replications and small region over which they would be efficient in a larger analysis. As shown in Figure 4 , moreover, the DEA scores for all departments usually are larger than and uncorrelated with the USNWR scores.
Benchmarking of national healthcare systems
Similar analyses can be conducted to compare entire national healthcare systems. For example, the World Health Organization (WHO) ranked the performance of 193 countries by assigning equal weights to several dozen measures of overall health, responsiveness, resources expended, and distribution of services (Musgrove et al., 2000) , although their study received a fair amount of criticism due to data, analysis methodology, weighting, and fairness issues (Alan, 2001; Jamison and Sandbu, 2001; Starfield, 2000) . Notes: All mortality, morbidity, and adverse event outputs converted to non-mortality, non-morbidity, and non-AE rates. Notes: T = Target (1st row), W = Weight (2nd row).
As an alternate approach, Benneyan et al. (2007) and Ceyhan and Benneyan (2008) applied DEA to a subset of these data across six healthcare system dimensions, summarised in Table 10 . In some cases, surrogate measures were used for a general dimension (e.g., immunisation rates as a marker for preventive care), with a total of five inputs and six outputs. All data were gathered from the WHO website 1 with the exception of the safety adverse event data, compiled from wrongdiagnosis.com. Although a small amount of missing data were imputed via multiple regression, thirteen of the 193 countries still were eliminated because most of their data were missing, with equity and safety measures both available for only 39 countries. Two separate analyses therefore were conducted, first only on these 39 counties with all measures and then on again all 180 countries, in the latter case both combined and partitioned into each of the WHO's four economic categories (based in gross national income per capita). The average healthy life expectancy measure was treated as bounded data (using an arbitrary upper bound of 80) and transformed via the OR approach. Table 11 summarises a sample (given space limitations) of the unrestricted DEA results for the larger data set (i.e., without safety and equity), where the first and second rows for each country again contain the target values and weights, respectively. One hundred and fifteen of the 180 countries were not on the best-in-class frontier, regardless of whether they have abundant inputs; for example, Jamaica and Japan both are efficient, whereas the USA and Turkey both are inefficient. Table 12 summarises the reference sets for those countries in Table 11 , with the percentage weights normalised to sum to 100% (representing the contributions of the reference countries for each particular healthcare system to become efficient). Again note that efficient healthcare systems do not have any others (other than themselves) in their reference sets. Table 13 lists all countries that were efficient only in the economic group analyses (left-hand columns) and those that were efficient in both sets of analyses (right-hand columns), in the second case indicating a sense of strong or robust efficiency and significant potential value in studying these national systems to gain valuable insights. In contrast, the USA healthcare system interestingly never exhibits efficiency, presumably because it does not transform the much higher levels of resources it consumes into proportionally higher levels of outputs (even under VRS assumptions). Figure 5 illustrates the small correlation between rankings produced by the WHO and DEA studies (for the CRS output-oriented unrestricted overall model). While almost statistically significant (p = 0.5192), the agreement is fairly weak with a correlation of R 2 = 0.048. Thirteen of the WHO's best performing countries are inefficient overall and in their respective economic groups, with the exceptions of only Japan and Switzerland, whereas some countries with the fewest healthcare resources and ranked poorly by the WHO are efficient in the DEA analysis.
Table 13
Summary of efficient national healthcare systems, overall and within economic groups 
Efficient only within economic group Efficient both within and between economic groups
Benchmarking at the regional state level
The same type of analysis also can be used to benchmark state and regional healthcare systems. In 2007, the Commonwealth Fund published a comparison of the relative performances of the healthcare systems of all US states based on a (subjectively) weighted score card analysis of 32 measures in five dimensions of care: outcomes, quality, access, efficiency, and equity (Cantor et al., 2007) . Their general methodology consensus-ranked the states for each measure separately, then rank ordered the systems within each dimension based on the average of their measure ranks within that dimension, and finally rank ordered the overall state healthcare systems based on their average dimension ranks. As an alternative, using a subset of these data, shown in Table 14 , Table 15 summarises the results of a DEA comparison of the state healthcare systems (Benneyan et al., 2007) . Again, note that the unbounded model assigned zero weights (italic cells) to some performance measures in order for many states to appear efficient. Conducting the same analysis with the weight restriction constraints listed below results in a 12.1% average decrease in efficiency scores, with only Hawaii, Maine, Massachusetts, Minnesota, Utah, and Vermont remaining efficient:
u 10 > u 1 .
(10) Figure 6 compares the frequency that each state is in another's reference set in the restricted and unrestricted cases, with Hawaii and Utah being the most frequent benchmarks in the weight restricted model, followed by Massachusetts, Minnesota, Michigan, and Vermont. As shown in Figure 7 and in contrast to the WHO results, fairly strong correlation exists between the CWF and weight-restricted DEA ranks (R 2 = 0.687, p = 0.000000037). In general, those states in the top quartile of the CWF study also were efficient in the DEA analysis, with the exception of New Hampshire, Rhode Island, Connecticut, Nebraska, and North Dakota; conversely, Utah was ranked 24th by the CWF but was still on the DEA efficiency frontier. 
Frequency (%)
Restricted weights Unrestricted weights 
Conclusion
DEA is an effective benchmarking tool that can help identify systems and processes on the best practice frontier, provide actionable targets to transform non-frontier systems to best-in-class, and identify comparators that each system should study and emulate. As such, DEA is a useful complement to other benchmarking methods and often produces different conclusions or additional insight, underscoring both its value and the value of more quantitatively considering the amounts of input resources consumed relative to outputs produced.
DEA adds particular value when there are multiple inputs and outputs to consider and when the relationships and best weighting structure among them are not immediately transparent, with the additional advantages of determining empirically achievable targets, identifying non-frontier DMUs that never can be called 'best' under any weighting scheme, and discovering possibly otherwise unidentified processes of excellence that other methods may miss. Good examples of this are the identification of Jamaica, Pakistan, Hawaii, and Utah as having very efficient healthcare systems, while most comparison and reform discussions tend to focus on a handful of more developed countries or industrialised states. Many of the DEA-best hospitals identified in Section 3.1 also typically are under-examined by Solucient, USNWR, and other popular benchmarking studies.
In contrast to these and other typical analyses that assign subjective or consensus weighting schemes to each of several criteria, DEA determines each system's optimal weights that maximise its score relative to the others. Since no other combination of weights can produce a higher relative score, results can be thought of as optimistic in the sense that DEA computes the best possible case for each DMU; conversely, any system not on the DEA frontier can never be efficient for any other set of weights, however chosen. An additional interpretation of the computed weights is that they somewhat reflect each system's intrinsic tradeoff values, lending insight to management styles and dispositions.
It also is important to understand the meaning of being on the DEA frontier and to not misinterpret results, namely that such DMUs are the most efficient among the particular set of DMUs being considered at transforming inputs into outputs, whereas 'inefficient' countries and hospitals (such as the US healthcare system and Tampa General Hospital's ENT department) still may produce very good outcomes, just at disproportionate costs. Since it is a relative rather than absolute measurement method, 'inefficient' DMUs also might perform very efficiently but just be outshone by others; conversely, the most efficient DMUs may not exhibit much excellence but simply be the best among a bad lot.
A sufficient number of DMUs also should be used to obtain useful differentiation between them, with a common rule-of-thumb being that it should exceed twice the total number of input and output categories. Too few DMUs or too many inputs and outputs can allow almost any system to appear efficient by placing most weight on a few variables in which it might excel, greatly limiting the practical value of the analysis (although this is less true as more weight restrictions are imposed). It also is important to structure the data such that all inputs and outputs are independent of one another for theoretical reasons (total operating costs and average physician salary being a possible counter-example). Finally, if the analyst has additional modelling insight about how inputs are transformed into outputs, related methods such as stochastic frontier analysis also can be appropriate.
With roughly 5700 hospitals in the USA alone, the potential to improve healthcare systems via benchmarking is significant. Basic DEA models usually will be sufficient for this purpose, although in some cases modelling issues such as those discussed above necessitate alternate methods. As demonstrated, the weight restriction and OR models offer the analyst simple solutions in such cases. Software and spreadsheet macros to perform all conventional and modified analyses illustrated in this paper are available from the lead author. Although treating the above examples with VRS or input-oriented models may produce different results, the primary intent here was to demonstrate the types of analyses possible and how they can be useful to improvement activities at department, hospital, or national levels. While not explored here, in a similar manner DEA also can be used to benchmark the performance of individual providers, such as cardiac surgeons (Chilingerian, 1995) . Taking a different viewpoint, Feng and Antony (2008) described using the DMAIC process to execute a DEA study, with each activity in the analysis mapping to one of the lettered steps (Define inputs and outputs, Measure their values, Analyse DEA results, Improve by benchmarking reference DMUs, and Control by measuring efficiency over time).
